SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+9.59%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$688M
AUM Growth
+$688M
(+9.4%)
Cap. Flow
+$4.88M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
65.8%
Holding
28
New
2
Increased
16
Reduced
6
Closed
2
Top Buys
| 1 |
Biogen
BIIB
|
$15.7M |
| 2 |
Abbott
ABT
|
$10.6M |
| 3 |
Gilead Sciences
GILD
|
$7.07M |
| 4 |
Tenet Healthcare
THC
|
$6.25M |
| 5 |
Bristol-Myers Squibb
BMY
|
$5.96M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$29.2M |
| 2 |
Eli Lilly
LLY
|
$15.3M |
| 3 |
Masimo
MASI
|
$5.18M |
| 4 |
Elevance Health
ELV
|
$4.74M |
| 5 |
United Therapeutics
UTHR
|
$3.92M |
Sector Composition
| 1 | Healthcare | 98.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Abbott
ABT
$231B
| $74.7M | 10.86% | 1,537,342 +218,700 | +17% | +$10.6M |
|
2
Baxter International
BAX
$12.7B
| $64.8M | 9.42% | 1,070,333 +34,100 | +3% | +$2.06M |
|
|
3
Bristol-Myers Squibb
BMY
$96B
| $49.6M | 7.2% | 889,390 +107,000 | +14% | +$5.96M |
|
4
Revvity
RVTY
$10.5B
| $43M | 6.25% | 631,308 +7,900 | +1% | +$538K |
|
5
Boston Scientific
BSX
$156B
| $39.8M | 5.79% | 1,437,480 +13,600 | +1% | +$377K |
|
|
6
Eli Lilly
LLY
$657B
| $39.1M | 5.69% | 475,250 -186,100 | -28% | -$15.3M |
|
|
7
Gilead Sciences
GILD
$140B
| $38.8M | 5.64% | 548,390 +99,900 | +22% | +$7.07M |
|
8
Ironwood Pharmaceuticals
IRWD
$214M
| $34.6M | 5.03% | 1,833,097 -107,681 | -6% | -$2.03M |
|
|
SHPG
9
DELISTED
Shire pic
SHPG
| $34.4M | 4.99% | 207,861 +27,100 | +15% | +$4.48M |
|
|
10
Elevance Health
ELV
$71.8B
| $33.8M | 4.91% | 179,410 -25,200 | -12% | -$4.74M |
|
11
Integra LifeSciences
IART
$1.18B
| $26.9M | 3.91% | 493,230 +5,000 | +1% | +$273K |
|
12
Bio-Rad Laboratories Class A
BIO
$8.06B
| $26M | 3.78% | 114,942 +900 | +0.8% | +$204K |
|
13
Perrigo
PRGO
$3.27B
| $22.1M | 3.22% | 293,140 +45,800 | +19% | +$3.46M |
|
14
McKesson
MCK
$85.4B
| $19.1M | 2.78% | 116,100 +900 | +0.8% | +$148K |
|
|
15
Masimo
MASI
$7.59B
| $18.4M | 2.67% | 201,418 -56,800 | -22% | -$5.18M |
|
|
PDCO
16
DELISTED
Patterson Companies, Inc.
PDCO
| $18.1M | 2.64% | 386,232 | – | – |
|
|
17
Biogen
BIIB
$19.4B
| $15.7M | 2.28% | +57,800 | New | +$15.7M |
|
18
Cigna
CI
$80.3B
| $14.1M | 2.05% | 84,270 | – | – |
|
19
Labcorp
LH
$23.1B
| $13.1M | 1.9% | 85,000 +1,100 | +1% | +$170K |
|
|
20
Tenet Healthcare
THC
$16.3B
| $11.1M | 1.62% | 575,180 +323,100 | +128% | +$6.25M |
|
21
Lexicon Pharmaceuticals
LXRX
$400M
| $10.2M | 1.49% | 622,655 +290,355 | +87% | +$4.78M |
|
|
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $10.2M | 1.49% | 605,545 -151,220 | -20% | -$2.56M |
|
|
LPNT
23
DELISTED
LifePoint Health, Inc.
LPNT
| $10.1M | 1.46% | 149,714 -15,000 | -9% | -$1.01M |
|
|
IPXL
24
DELISTED
Impax Laboratories, Inc.
IPXL
| $9.49M | 1.38% | 589,311 +55,000 | +10% | +$886K |
|
25
Owens & Minor
OMI
$378M
| $5.66M | 0.82% | 175,874 +30,000 | +21% | +$966K |
|